| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1480155A Method for lowering antigenicity of blood coagulation substance complex from nonhuman mammal and method for sterilizing bacterium |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703378 Vitreoretinal tamponades based on fluorosilicone fluids |
| 03/09/2004 | US6702839 Method of controlling body temperature while reducing shivering |
| 03/09/2004 | CA2322188C The use of fumaric acid derivatives in transplant medicine |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 03/04/2004 | WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases |
| 03/04/2004 | WO2004001020A3 Methods and means to promote gut absorption |
| 03/04/2004 | WO2002089675A9 Wound closure system and methods |
| 03/04/2004 | US20040043992 Prevention vascular occlusion |
| 03/04/2004 | US20040043937 Antiinflammatory agents; osteoporosis; thrombosis; grafting of organs |
| 03/04/2004 | US20040043016 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation |
| 03/04/2004 | US20040043007 Transfection system |
| 03/02/2004 | US6699493 Performing the transplant, and implanting in the eye a biodegradable drug delivery system comprising an immunosuppressant and a biodegradable polymer |
| 02/26/2004 | WO2003103575A3 Compounds, compositions, and methods |
| 02/26/2004 | WO2003072024A3 Methods of treating vascular disease |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 02/26/2004 | WO2002022112A3 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 02/26/2004 | US20040038934 Preparation from bis2-(N'-ethylcarbodimido)ethyldisulfide, hyaluronic acid and a reducing agent; useful in ophthalmic surgery and in tissue engineering. |
| 02/26/2004 | US20040038907 For healing wounds/tissue repair |
| 02/26/2004 | US20040038893 Prevention and reduction of blood loss |
| 02/26/2004 | US20040038293 Antibodies to human cd154 |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | CN1478067A O-substituted 6-methyl-tramadol derivatives |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2003070188A3 Method of treating trx mediated diseases |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | US20040033952 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033951 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033946 Cell damage inhibitor |
| 02/19/2004 | US20040033212 Isolated population of superficial zone chondroprogenitor cells; replacement of damaged cartilage |
| 02/19/2004 | DE10237423A1 Treating immunological (or related) diseases, e.g. inflammatory bowel disease, rheumatoid arthritis or psoriasis, comprises administration of 3-methylene-2-indolinone derivative or quinazoline compound |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1233786B1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance for the preparation of a medicament |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/12/2004 | WO2004013138A2 Imidazo`1,2-a!pyridines |
| 02/12/2004 | WO2003062467A3 Tissue rejection |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029820 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040028815 Combinatorial synthesis |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387686A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection |
| 02/11/2004 | EP1069902B1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 02/11/2004 | CN1473572A Hyaluronic acid gel with iron ion and medicine used for preventing adhesion after operation |
| 02/11/2004 | CN1137723C Enhanced wound coverage and composition to enhance wound healing |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/05/2004 | US20040023900 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/05/2004 | US20040023883 IGF-I and insulin variants are provided that selectively bind to IGFBP-1 or IGFBP-3. These agonist variants are useful, for example, to improve the half-lives of IGF-I and insulin, respectively. |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/04/2004 | EP1385504A1 Method of inhibiting adhesion formation |
| 02/03/2004 | US6686360 N-benzylpiperazine compounds |
| 02/03/2004 | US6685963 Diphasic injection composition containing dispersed and continuous phases useful for reparative and plastic surgery |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 01/29/2004 | US20040019191 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 01/29/2004 | US20040019093 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them |
| 01/29/2004 | US20040018995 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; antidiabetic agents |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/22/2004 | US20040014960 Amidation with chitosans; for prevention of adhesion after surgical operation, correction of facial wrinkles, dermal augmentation, tissue engineering, and osteoarthritic viscosupplement |
| 01/22/2004 | US20040014634 Thieno[2,3-d]pyrimidinediones and their use as pharmaceuticals |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1280799B1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | WO2003063904A3 Tissue adhesion formation control |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010023 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/14/2004 | CN1468262A Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2003055531A8 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |
| 01/08/2004 | WO2002092075A3 Therapeutic delivery of carbon monoxide |
| 01/08/2004 | WO2002036751A3 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/07/2004 | CN1466567A Substituted 1-aminobutan-3-01 derivatives |
| 01/07/2004 | CN1133612C Bamboo parasitic fungus extract and its preparation and application |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/01/2004 | US20040001821 Topical applying kinase to eye surface |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004000331A1 Organ arrest, protection, preservation and recovery |
| 12/31/2003 | CN1463984A Medicinal collagen material and its making process |
| 12/31/2003 | CN1132557C 靶向局部治疗疾病的装置 Targeting apparatus topical treatment of diseases |
| 12/31/2003 | CA2489930A1 Methods and means to promote gut absorption |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/24/2003 | WO2003105666A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |